Description
ADDAMOXY 625 is a powerful combination of Amoxycillin 500mg and Clavulanic Acid 125mg designed to combat beta-lactamase-producing bacterial infections. Amoxycillin offers broad-spectrum antibacterial coverage, while Clavulanic Acid enhances its effectiveness by inhibiting resistant bacterial enzymes. This FDA-approved formulation is widely prescribed for respiratory infections such as acute bronchitis, community-acquired pneumonia, and sinusitis. It is also effective against urinary tract infections, skin and soft tissue infections, post-surgical infections, and bone and joint infections. ADDAMOXY 625 ensures targeted therapy, faster recovery, and reliable clinical outcomes against gram-positive and gram-negative strains.